SCHEMBL7963959

SCHEMBL7963959

Cc1ccc(N2CCN(CCCc3onc4c3CCCC4)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HTR7 P34969 3/20 0.41
PLA2G2A P14555 3/20 0.41
SLC27A1 Q6PCB7 1/20 0.40
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
HRH1 P35367 1/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965107 0.89 SIGMAR1 (0.51) MAPTHTR7KDM4ESIGMAR1HRH1
SCHEMBL7949605 0.89 DRD2 (0.48) SLC27A1SIGMAR1HRH1
SCHEMBL7959798 0.88 DRD2 (0.47) SLC27A1SIGMAR1HRH1
SCHEMBL7963539 0.88 SIGMAR1 (0.50) MAPTHTR7KDM4ESIGMAR1HRH1
Hydrochloric Acid SCHEMBL7960917 0.87 SIGMAR1 (0.49) MAPTHTR7KDM4ESIGMAR1HRH1
Hydrochloric Acid SCHEMBL7959877 0.84 DRD3 (0.51) HTR7SIGMAR1HRH1
SCHEMBL7961291 0.81 SIGMAR1 (0.40) ADRA1DADRA1AADRA1BTSHRALDH1A1
SCHEMBL7959657 0.79 SIGMAR1 (0.51) HTR7SIGMAR1
SCHEMBL5776790 0.78 MAPT (0.45) MAPTNPSR1HTR7SLC27A1ADRA1D
SCHEMBL5775439 0.78 MAPT (0.45) MAPTNPSR1HTR7SLC27A1ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed